由1例经临床药师会诊的重症感染病例谈临床药学服务的持续改进  

Pharmaceutical Intervention for 1 Case of Severely Infected Patient by Clinical Pharmacist and The PDCA of Pharmaceutical Care

作　　者：白红[1] 李亚骞[1] 陈龙[1] 官真水 

机构地区：[1]成都市双流县第一人民医院药剂科,四川成都610200

出　　处：《中国医药指南》2012年第31期25-27,共3页Guide of China Medicine

摘　　要：目的讨论临床药师在参与制定和调整特殊管理抗菌药物的治疗方案中发挥的作用。方法回顾性分析1例由临床药师会诊并持续监护的重症感染患者的药物治疗过程。结果临床药师通过全程监护患者的治疗过程,能及时协助医师调整方案,发现药物不良反应,为临床医师提供极大的帮助,患者最终病情好转。结论在监护患者的过程中发现问题并解决,同时提高自己,体现了临床药师工作的持续改进。Objective To discuss the role the clinical pharmacist plays in the anti-microbial treatment designing and modifying process.Methods Analyse one particular severe septicaemia＇s treatment course consulted and assisted by a clinical pharmacist.Results The clinical pharmacist through monitoring the whole process of patient＇s treatment,could discern the ADR and alter the dosing regimen timely,therefore helping the clinician greatly.The patient was cured and eventually healed.Conclusion This successful case,is a good demonstration of the PDCA--＂Plan,Do,Check,Action＂.And the execution of The PDCA standard will lead to a higher requirement for the clinical pharmacist,and a new level of the clinical pharmacist expertise.

关 键 词：临床药师 药学监护 持续改进 

分 类 号：R95[医药卫生—药学]